The synthesis and pharmacological evaluation of 4-alicyclic (hydroxy)methyl- and 4-hydroxyalicyclic-1,2,3-benzotriazines

R Grayshan, D D Miller

    Research output: Contribution to journalArticlepeer-review

    5 Citations (Scopus)


    The syntheses of 4-[1-adamantyl(hydroxy)methyl]-, 4-[1-methylcyclohexyl(hydroxy)methyl]-, and 4-(2-hydroxycyclohexyl)-1,2,3-benzotriazines are described as structural variants of the usual 4-substituted-immuno-1,2,3-benzotriazines that have been shown to possess anti-arrhythmic activity as their N-2 alkyl halides or sulphonates. These compounds showed a wide variation in aqueous solubility but were devoid of any anti-arrhythmic activity both as parent compounds and as their methyl carbamate derivatives.

    Original languageEnglish
    Pages (from-to)87-90
    Number of pages4
    JournalEuropean Journal of Medicinal Chemistry
    Issue number1
    Publication statusPublished - 1986


    Dive into the research topics of 'The synthesis and pharmacological evaluation of 4-alicyclic (hydroxy)methyl- and 4-hydroxyalicyclic-1,2,3-benzotriazines'. Together they form a unique fingerprint.

    Cite this